Novo Nordisk A/S (BSP:N1VO34) Other Current Payables : R$0 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Novo Nordisk A/S Other Current Payables?

Novo Nordisk A/S's Other Current Payables for the quarter that ended in Dec. 2023 was R$0 Mil.

Novo Nordisk A/S's quarterly Other Current Payables stayed the same from Jun. 2023 (R$0 Mil) to Sep. 2023 (R$0 Mil) but then increased from Sep. 2023 (R$0 Mil) to Dec. 2023 (R$0 Mil).

Novo Nordisk A/S's annual Other Current Payables declined from Dec. 2021 (R$0 Mil) to Dec. 2022 (R$0 Mil) but then increased from Dec. 2022 (R$0 Mil) to Dec. 2023 (R$0 Mil).

Novo Nordisk A/S Other Current Payables Historical Data

The historical data trend for Novo Nordisk A/S's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Nordisk A/S Other Current Payables Chart

Novo Nordisk A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Payables

Get a 7-Day Free Trial

Novo Nordisk A/S Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Current Payables	Get a 7-Day Free Trial															-	-	-	-	-

Novo Nordisk A/S Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Novo Nordisk A/S Other Current Payables Related Terms

Thank you for viewing the detailed overview of Novo Nordisk A/S's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

Novo Nordisk A/S (BSP:N1VO34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novo Nordisk A/S (BSP:N1VO34) » Definitions » Other Current Payables

Comparable Companies

Traded in Other Exchanges

NONOF:USA NVO:USA NOVOB:Mexico NVO:Mexico NOVOBc:UK 0QIU:UK NOVO B:Denmark NOV:Germany NNO2:Austria

Address

Novo Alle 1, Bagsvaerd, DNK, DK-2880

Website

https://www.novonordisk.com

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Novo Nordisk A/S (BSP:N1VO34) Headlines

No Headlines